Excel Endodontics, a new specialty dental practice founded by endodontist Dr. Rachel Halpern, is proud to announce its official opening in Marlboro, New Jersey, along with the...
Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a leading global provider of innovative in vitro diagnostic technologies, is expanding its QUICKVUE...
Aetna®, a CVS Health® company (NYSE: CVS), today announced it will scale the Aetna Clinical Collaboration (ACC) program to ten hospitals by year-end, with implementations underway with AdventHealth...
Unified Brand and Lucet™ at Home Reflects the Integration of Lucet and Emcara Health and a Shared Commitment to Expanding Access and Improving Clinical Outcomes. Lucet,...
WeDosify becomes CLM’s first commercially available product – delivering data-driven, adaptive dosing recommendations to improve GLP-1 adherence. Informed by 29 studies and 15,000+ patient profiles;...
Findings published in Advance Sciences reveal a novel molecular reaction that slows down sugar metabolism, reducing inflammatory cell death Researchers are closing in on new ways to...
TIME honors Butterfly’s role in advancing accessible diagnostic imaging Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body...
Neuroscience company Panaxium Research Inc. is developing personalized neurostimulation therapies to restore lost motor function following stroke and traumatic brain injury. Its platform integrates proprietary...
Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opzelura® (ruxolitinib) cream 1.5%, a topical Janus kinase (JAK) inhibitor, for...
Celltrion today announced that Health Canada has approved Stoboclo® and Osenvelt® (CT-P41), biosimilars referencing Prolia® and Xgeva®, respectively for all indications of reference products.1,2 “The approval of Stoboclo...
‘FORTIFY’ Selects FAI-Score™ as Primary Outcome Measure, and Caristo as Worldwide Imaging Core Lab for Coronary Inflammation and Plaque Measurement and Monitoring Caristo Diagnostics, on a mission...
Spearheaded by the Malaysia Healthcare Travel Council, the event builds momentum towards the Malaysia Year of Medical Tourism 2026. Building on Malaysia’s established reputation as a premier...
NetworkNewsWire Editorial Coverage Progress in RNA-based medicines, immunotherapies and targeted treatments is not simply desirable, it is a critical necessity. Deadly cancers such as glioblastoma...
SAM Medical, a leading provider of pre-hospital emergency medical products, is pleased to announce the acquisition of TyTek Medical, part of the TyTek Group. TyTek...
Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major cardiovascular events...